File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Features of the new pandemic influenza A/H1N1/2009 virus: Virology, epidemiology, clinical and public health aspects

TitleFeatures of the new pandemic influenza A/H1N1/2009 virus: Virology, epidemiology, clinical and public health aspects
Authors
Issue Date2010
PublisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.co-pulmonarymedicine.com
Citation
Current Opinion In Pulmonary Medicine, 2010, v. 16 n. 3, p. 235-241 How to Cite?
AbstractPurpose of Review: The emergence of the pandemic A/H1N1/2009 influenza virus has enabled preexisting pandemic influenza plans to be put into action. This review examines the clinical and public health impact of this new virus. Recent Findings: Although early figures suggested that this pandemic virus was causing higher morbidity and mortality than seasonal influenza viruses, subsequent studies have found it to cause milder disease in most cases. Yet, there are some groups with increased risk of serious disease from this new pathogen. The widespread use of antiviral agents, prophylactically and therapeutically, has led to the sporadic emergence of drug resistance, though this is still rare. Nonpharmacological public health interventions for containment and mitigation have been relatively ineffective in limiting the rapid, global spread of this pathogen. Recently, the focus has been on the manufacture and distribution of various specific vaccines against this new virus, and the care of severely ill patients admitted to intensive care. Summary: As this virus continues to infect new members of the global population, it may eventually become just one of the annual circulating seasonal influenza viruses. Until then, it will be prudent to continue to monitor it closely for any signs of enhanced transmissibility and virulence. © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.
Persistent Identifierhttp://hdl.handle.net/10722/182373
ISSN
2015 Impact Factor: 3.079
2015 SCImago Journal Rankings: 1.397
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorTang, JWen_US
dc.contributor.authorShetty, Nen_US
dc.contributor.authorLam, TTYen_US
dc.date.accessioned2013-04-23T08:21:10Z-
dc.date.available2013-04-23T08:21:10Z-
dc.date.issued2010en_US
dc.identifier.citationCurrent Opinion In Pulmonary Medicine, 2010, v. 16 n. 3, p. 235-241en_US
dc.identifier.issn1070-5287en_US
dc.identifier.urihttp://hdl.handle.net/10722/182373-
dc.description.abstractPurpose of Review: The emergence of the pandemic A/H1N1/2009 influenza virus has enabled preexisting pandemic influenza plans to be put into action. This review examines the clinical and public health impact of this new virus. Recent Findings: Although early figures suggested that this pandemic virus was causing higher morbidity and mortality than seasonal influenza viruses, subsequent studies have found it to cause milder disease in most cases. Yet, there are some groups with increased risk of serious disease from this new pathogen. The widespread use of antiviral agents, prophylactically and therapeutically, has led to the sporadic emergence of drug resistance, though this is still rare. Nonpharmacological public health interventions for containment and mitigation have been relatively ineffective in limiting the rapid, global spread of this pathogen. Recently, the focus has been on the manufacture and distribution of various specific vaccines against this new virus, and the care of severely ill patients admitted to intensive care. Summary: As this virus continues to infect new members of the global population, it may eventually become just one of the annual circulating seasonal influenza viruses. Until then, it will be prudent to continue to monitor it closely for any signs of enhanced transmissibility and virulence. © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.en_US
dc.languageengen_US
dc.publisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.co-pulmonarymedicine.comen_US
dc.relation.ispartofCurrent Opinion in Pulmonary Medicineen_US
dc.subject.meshAnimalsen_US
dc.subject.meshAntiviral Agents - Therapeutic Useen_US
dc.subject.meshCommunicable Disease Control - Trendsen_US
dc.subject.meshDisease Outbreaks - Prevention & Control - Statistics & Numerical Dataen_US
dc.subject.meshFemaleen_US
dc.subject.meshFollow-Up Studiesen_US
dc.subject.meshForecastingen_US
dc.subject.meshHumansen_US
dc.subject.meshIncidenceen_US
dc.subject.meshInfluenza A Virus, H1n1 Subtype - Drug Effects - Isolation & Purificationen_US
dc.subject.meshInfluenza Vaccines - Administration & Dosageen_US
dc.subject.meshInfluenza, Human - Epidemiology - Prevention & Control - Virologyen_US
dc.subject.meshMaleen_US
dc.subject.meshPrimary Prevention - Methodsen_US
dc.subject.meshPublic Healthen_US
dc.subject.meshRisk Assessmenten_US
dc.subject.meshSurvival Analysisen_US
dc.subject.meshSwineen_US
dc.subject.meshTreatment Outcomeen_US
dc.subject.meshVaccination - Methodsen_US
dc.titleFeatures of the new pandemic influenza A/H1N1/2009 virus: Virology, epidemiology, clinical and public health aspectsen_US
dc.typeArticleen_US
dc.identifier.emailLam, TTY: ttylam@hku.hken_US
dc.identifier.authorityLam, TTY=rp01733en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1097/MCP.0b013e3283375727en_US
dc.identifier.pmid20375785-
dc.identifier.scopuseid_2-s2.0-77951034603en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77951034603&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume16en_US
dc.identifier.issue3en_US
dc.identifier.spage235en_US
dc.identifier.epage241en_US
dc.identifier.isiWOS:000276954000010-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridTang, JW=35273734900en_US
dc.identifier.scopusauthoridShetty, N=7005372453en_US
dc.identifier.scopusauthoridLam, TTY=36775821700en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats